| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total other income (expense), net | -269 | -385 | -767 | 322 |
| Income before income taxes | 23,031 | 36,182 | 26,676 | 4,245 |
| Current income tax expense (benefit) | - | - | - | 29 |
| (provision) benefit for income taxes | -1,288 | 1,275 | 994 | - |
| Net income | 24,319 | 34,907 | 25,682 | 4,216 |
| Earnings per share, basic, total | 0.71 | 1.03 | 0.76 | 0.13 |
| Earnings per share, diluted, total | 0.66 | 0.92 | 0.7 | 0.12 |
| Weighted average common shares outstanding, diluted | 40,748,023 | 40,558,953 | 39,914,487 | 35,683,952 |
| Weighted average number of shares outstanding, basic, total | 34,112,452 | 33,912,669 | 33,721,603 | 33,441,394 |
TransMedics Group, Inc. (TMDX)
TransMedics Group, Inc. (TMDX)